biotech
July 23, 2021
Amgen Denied Petition to Rehear Enablement Requirements for Biotech Patents By: Katie Rubino On June 21, 2021 the Court of Appeals for the Federal Circuit […]
October 31, 2018
According to IP experts, outside of technical limitations of blockchain technology, the greatest challenge to becoming mainstream is a lack of trust (no pun intended) that prevents many companies from adopting blockchain into their structure.